HomePPGN • SWX
add
Polypeptide Group AG
Previous close
CHF 18.16
Day range
CHF 17.20 - CHF 18.10
Year range
CHF 15.26 - CHF 35.80
Market cap
587.76M CHF
Avg Volume
83.34K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
In the news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 100.87M | 7.01% |
Operating expense | 10.56M | 15.31% |
Net income | -4.09M | 52.38% |
Net profit margin | -4.05 | 55.54% |
Earnings per share | — | — |
EBITDA | 7.70M | 736.13% |
Effective tax rate | -40.18% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 68.28M | -28.66% |
Total assets | 756.58M | 9.79% |
Total liabilities | 399.33M | 29.71% |
Total equity | 357.24M | — |
Shares outstanding | 33.00M | — |
Price to book | 1.68 | — |
Return on assets | 1.09% | — |
Return on capital | 1.79% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -4.09M | 52.38% |
Cash from operations | 44.46M | 4.86% |
Cash from investing | -29.40M | -106.91% |
Cash from financing | -6.51M | -141.94% |
Net change in cash | 9.90M | -77.17% |
Free cash flow | -21.85M | -176.99% |
About
Founded
1952
Headquarters
Website
Employees
1,362